| Date Filed | Type | Description |
| 07/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/09/2023 |
4
| Wahlstrom Mats (Director) has filed a Form 4 on Coherus BioSciences, Inc.|
Txns:
| Granted 38,250 options to buy
@ $5.38, valued at
$205.8k
|
|
| 06/09/2023 |
4
| STOLPER MARK (Director) has filed a Form 4 on Coherus BioSciences, Inc.|
Txns:
| Granted 38,250 options to buy
@ $5.38, valued at
$205.8k
|
|
| 06/09/2023 |
4
| Newcomer Lee Nisley (Director) has filed a Form 4 on Coherus BioSciences, Inc.|
Txns:
| Granted 38,250 options to buy
@ $5.38, valued at
$205.8k
|
|
| 06/09/2023 |
4
| TZOUMAKAS KIMBERLY JO (Director) has filed a Form 4 on Coherus BioSciences, Inc.|
Txns:
| Granted 38,250 options to buy
@ $5.38, valued at
$205.8k
|
|
| 06/09/2023 |
4
| O'Donnell-Tormey Jill (Director) has filed a Form 4 on Coherus BioSciences, Inc.|
Txns:
| Granted 38,250 options to buy
@ $5.38, valued at
$205.8k
|
|
| 06/09/2023 |
4
| Newton Charles W. (Director) has filed a Form 4 on Coherus BioSciences, Inc.|
Txns:
| Granted 38,250 options to buy
@ $5.38, valued at
$205.8k
|
|
| 04/04/2023 |
4
| Vexler Vladimir (Chief Scientific Officer) has filed a Form 4 on Coherus BioSciences, Inc.|
Txns:
| Paid exercise price by delivering 16,278 shares
@ $6.84, valued at
$111.3k
|
|
| 04/04/2023 |
4
| Reider Paul (Chief Commercial Officer) has filed a Form 4 on Coherus BioSciences, Inc.|
Txns:
| Paid exercise price by delivering 2,451 shares
@ $6.84, valued at
$16.8k
|
|
| 04/04/2023 |
4
| Stilwell McDavid (CFO) has filed a Form 4 on Coherus BioSciences, Inc.|
Txns:
| Paid exercise price by delivering 3,457 shares
@ $6.84, valued at
$23.6k
|
|
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/28/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/24/2023 |
4
| Lanfear Dennis M (President & CEO) has filed a Form 4 on Coherus BioSciences, Inc.|
Txns:
| Granted 86,250 shares
@ $0 |
|
| 01/24/2023 |
4
| McMichael Bryan J (See Remarks) has filed a Form 4 on Coherus BioSciences, Inc.|
Txns:
| Granted 12,500 shares
@ $0 |
|
| 01/24/2023 |
4
| Vexler Vladimir (Chief Scientific Officer) has filed a Form 4 on Coherus BioSciences, Inc.|
Txns:
| Granted 40,000 shares
@ $0 |
|
| 01/24/2023 |
4
| Stilwell McDavid (CFO) has filed a Form 4 on Coherus BioSciences, Inc.|
Txns:
| Granted 40,000 shares
@ $0 |
|
| 01/12/2023 |
4
| Vexler Vladimir (Chief Scientific Officer) has filed a Form 4 on Coherus BioSciences, Inc.|
Txns:
| Paid exercise price by delivering 3,602 shares
@ $9.85, valued at
$35.5k
Paid exercise price by delivering 3,602 shares
@ $10.26, valued at
$37k
|
|
| 01/10/2023 |
4
| McMichael Bryan J (See Remarks) has filed a Form 4 on Coherus BioSciences, Inc.|
Txns:
| Paid exercise price by delivering 1,699 shares
@ $9.58, valued at
$16.3k
|
|
| 01/06/2023 |
4
| Lanfear Dennis M (President & CEO) has filed a Form 4 on Coherus BioSciences, Inc.|
Txns:
| Paid exercise price by delivering 10,905 shares
@ $9.87, valued at
$107.6k
Granted 402,500 options to buy
@ $10.37, valued at
$4.2M
|
|
| 01/06/2023 |
4
| McMichael Bryan J (See Remarks) has filed a Form 4 on Coherus BioSciences, Inc.|
Txns:
| Granted 25,000 options to buy
@ $9.87, valued at
$246.8k
|
|
| 01/06/2023 |
4
| Vexler Vladimir (Chief Scientific Officer) has filed a Form 4 on Coherus BioSciences, Inc.|
Txns:
| Paid exercise price by delivering 5,437 shares
@ $9.87, valued at
$53.7k
Granted 80,000 options to buy
@ $9.87, valued at
$789.6k
|
|
| 01/06/2023 |
4
| Stilwell McDavid (CFO) has filed a Form 4 on Coherus BioSciences, Inc.|
Txns:
| Paid exercise price by delivering 5,437 shares
@ $9.87, valued at
$53.7k
Granted 80,000 options to buy
@ $9.87, valued at
$789.6k
|
|
| 01/04/2023 |
4
| Lanfear Dennis M (President & CEO) has filed a Form 4 on Coherus BioSciences, Inc.|
Txns:
| Gifted 4,000 shares
@ $0 |
|
| 09/09/2022 |
4
| McMichael Bryan J (See Remarks) has filed a Form 4 on Coherus BioSciences, Inc.|
Txns:
| Granted 15,000 options to buy
@ $10.78, valued at
$161.7k
|
|
| 09/09/2022 |
3
| McMichael Bryan J (See Remarks) has filed a Form 3 on Coherus BioSciences, Inc. |
| 05/20/2022 |
4
| O'Donnell-Tormey Jill (Director) has filed a Form 4 on Coherus BioSciences, Inc.|
Txns:
| Granted 54,000 options to buy
@ $7.45, valued at
$402.3k
|
|
| 05/20/2022 |
3
| O'Donnell-Tormey Jill (Director) has filed a Form 3 on Coherus BioSciences, Inc. |
| 05/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/06/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/05/2022 |
4
| Stilwell McDavid (CFO) has filed a Form 4 on Coherus BioSciences, Inc.|
Txns:
| Paid exercise price by delivering 3,458 shares
@ $12.85, valued at
$44.4k
|
|
| 04/05/2022 |
4
| Vexler Vladimir (Chief Scientific Officer) has filed a Form 4 on Coherus BioSciences, Inc.|
Txns:
| Paid exercise price by delivering 3,458 shares
@ $12.85, valued at
$44.4k
|
|
| 03/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|